Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate

Laboratory Investigation

Volumn 94, Issue 2, 2014, Pages 208-221

  Maund, Sophia Lisette ^a   Nolley, Rosalie ^a   Peehl, Donna Mae ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ex vivo; model development; prostate; prostate cancer; tissue slice culture

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE OPTIMIZATION; GENETIC TRAIT; HUMAN; IMMUNOHISTOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SIGNAL TRANSDUCTION; TISSUE CHARACTERIZATION; TISSUE CULTURE; TISSUE DEGENERATION; TISSUE SLICE; TISSUE STRUCTURE;

ANDROGENS; HUMANS; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MALE; MICROTOMY; MODELS, BIOLOGICAL; PROSTATE; PROSTATIC NEOPLASMS; TISSUE CULTURE TECHNIQUES;

EID: 84893287990     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.141     Document Type: Article

References (53)

1. Pienta KJ, Abate-Shen C, Agus DB, et al. The current state of preclinical prostate cancer animal models. Prostate 2008;68:629-639.
2. Toivanen R, Taylor RA, Pook DW, et al. Breaking through a roadblock in prostate cancer research: an update on human model systems. J Steroid Biochem Mol Biol 2012;131:122-131.
3. Taylor RA, Risbridger GP. Prostatic tumor stroma: a key player in cancer progression. Current Cancer Drug Targets 2008;8:490-497.
4. Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004;64:2270-2305.
5. Peehl DM. Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 2005;12:19-47.
6. Parrish AR, Gandolfi AJ, Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci 1995;57: 1887-1901.
7. Holliday DL, Moss MA, Pollock S, et al. The practicalities of using tissue slices as preclinical organotypic breast cancer models. J Clin Pathol 2013;66:253-255.
8. Fisher RL, Vickers AE. Preparation and culture of precision-cut organ slices from human and animal. Xenobiotica 2013;43:8-14.
9. Enk CD, Jacob-Hirsch J, Gal H, et al. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 2006;25:2601-2614.
10. Schmid JO, Dong M, Haubeiss S, et al. Cancer cells cue the p53 response of cancer-associated fibroblasts to cisplatin. Cancer Res 2012;72:5824-5832.
11. Jacobs ER, Bodiga S, Ali I, et al. Tissue protection and endothelial cell signaling by 20-HETE analogs in intact ex vivo lung slices. Exp Cell Res 2012;318:2143-2152.
12. Brauer HA, Makowski L, Hoadley KA, et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 2013;19:571-585.
13. Graaf IA, Groothuis GM, Olinga P. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Exp Opin Drug Metab Toxicol 2007;3:879-898.
14. Keshari KR, Sriram R, Van Criekinge M, et al. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Prostate 2013;73:1171-1181.
15. Vaira V, Fedele G, Pyne S, et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci USA 2010;107:8352-8356.
16. Varani J, Dame MK, Wojno K, et al. Characteristics of nonmalignant and malignant human prostate in organ culture. Lab Invest 1999;79: 723-731.
17. Papini S, Rosellini A, Campani D, et al. Selective growth of epithelial basal cells from human prostate in a three-dimensional organ culture. Prostate 2004;59:383-392.
18. Parrish AR, Sallam K, Nyman DW, et al. Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biol Toxicol 2002;18:205-219.
19. Blauer M, Tammela TL, Ylikomi T. A novel tissue-slice culture model for non-malignant human prostate. Cell Tissue Res 2008;332:489-498.
20. Ni X, Zhang Y, Ribas J, et al. Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. J Clin Invest 2011;121:2383-2390.
21. Kiviharju-af Hallstrom TM, Jaamaa S, Monkkonen M, et al. Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement. Proc Natl Acad Sci USA 2007;104:7211-7216.
22. Jaamaa S, Af Hallstrom TM, Sankila A, et al. DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. Cancer Res 2010;70:8630-8641.
23. Zhu L, Jaamaa S, Af Hallstrom TM, et al. PSA forms complexes with alpha(1) -antichymotrypsin in prostate. Prostate 2013;73:219-226.
24. Jaamaa S, Sankila A, Rantanen V, et al. Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate. Prostate 2012;72:1060-1070.
25. Behrsing HP, Vickers AE, Tyson CA. Extended rat liver slice survival and stability monitored using clinical biomarkers. Biochem Biophys Res Commun 2003;312:209-213.
26. Amin K, Ip C, Sato B, et al. Characterization of ANIT-induced toxicity using precision-cut rat and dog liver slices cultured in a dynamic organ roller system. Toxicolo Pathol 2006;34:776-784.
27. Ahlgren H, Henjum K, Ottersen OP, et al. Validation of organotypical hippocampal slice cultures as an ex vivo model of brain ischemia: different roles of NMDA receptors in cell death signalling after exposure to NMDA or oxygen and glucose deprivation. Cell Tissue Res 2011;345:329-341.
28. Golovine KV, Makhov PB, Teper E, et al. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate 2013;73:23-30.
29. Krumdieck CL. Development of a live tissue microtome: reflections of an amateur machinist. Xenobiotica 2013;43:2-7.
30. Peehl DM. Human prostatic epithelial cells. In: Freshney R, Freshney M (eds). Culture of Epithelial Cells. 2nd edn., New York, NY, USA, 2002, pp 171-194.
31. Zhao H, Nolley R, Chen Z, et al. Tissue slice grafts: an in vivo model of human prostate androgen signaling. Am J Pathol 2010;177: 229-239.
32. Sun L, Gu L, Wang S, et al. N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity. PLoS ONE 2012;7:e32503.
33. Krause MS, McClenaghan NH, Flatt PR, et al. L-arginine is essential for pancreatic beta-cell functional integrity, metabolism and defense from inflammatory challenge. J Endocrinol 2011;211:87-97.
34. Ghoumari AM, Dusart I, El-Etr M, et al. Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum. Proc Natl Acad Sci USA 2003;100:7953-7958.
35. Tilles AW, Baskaran H, Roy P, et al. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng 2001;73: 379-389.
36. Rambani K, Vukasinovic J, Glezer A, et al. Culturing thick brain slices: an interstitial 3D microperfusion system for enhanced viability. J Neurosci Methods 2009;180:243-254.
37. Schumacher K, Khong YM, Chang S, et al. Perfusion culture improves the maintenance of cultured liver tissue slices. Tissue Eng 2007; 13:197-205.
38. Dabir PD, Ottosen P, Hoyer S, et al. Comparative analysis of three-and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma. Diagn Pathol 2012;7:81.
39. Cunha GR, Hayward SW, Wang YZ. Role of stroma in carcinogenesis of the prostate. Differentiation 2002;70:473-485.
40. De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011;60:106-117.
41. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24:220-226.
42. di Santagnese PA. Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments. Ann Oncol 2001; 12(Suppl 2):S135-S140.
43. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-648.
44. Chaux A, Albadine R, Toubaji A, et al. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011;35:1014-1020.
45. Kwabi-Addo B, Giri D, Schmidt K, et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 2001;98:11563-11568.
46. McMenamin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 1999;59:4291-4296.
47. Wright Jr GL, Haley C, Beckett ML, et al. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol 1995;1:18-28.
48. Jaggi M, Johansson SL, Baker JJ, et al. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 2005;23:402-406.
49. Vickers AE, Fisher RL. Evaluation of drug-induced injury and human response in precision-cut tissue slices. Xenobiotica 2013;43:29-40.
50. Centenera MM, Gillis JL, Hanson AR, et al. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res 2012;18:3562-3570.
51. Raj L, Ide T, Gurkar AU, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011;475:231-234.
52. Meneghel-Rozzo T, Rozzo A, Poppi L, et al. In vivo and in vitro development of mouse pancreatic beta-cells in organotypic slices. Cell Tissue Res 2004;316:295-303.
53. Sonpavde G, Palapattu GS. Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials. Exp Rev Anticancer Ther 2010;10:439-450.